{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:08:42Z","timestamp":1792454922400,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cgh.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:12:31Z","timestamp":1782879151000},"page":"2359-2369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert Review"],"prefix":"10.1016","volume":"24","author":[{"given":"Monika","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron P.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-0780","authenticated-orcid":false,"given":"Anne F.","family":"Peery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen R.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.05.007_bib1","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.05.007_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmi.2018.12.007","article-title":"Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study","volume":"25","author":"Gentry","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2026.05.007_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijantimicag.2013.08.013","article-title":"Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection","volume":"42","author":"Lam","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cgh.2026.05.007_bib4","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.cgh.2019.12.029","article-title":"Fecal microbiota transplant decreases mortality in patients with refractory severe or fulminant Clostridioides difficile infection","volume":"18","author":"Cheng","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.007_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/cid\/cix762","article-title":"Early fecal microbiota transplantation improves survival in severe Clostridium difficile infections","volume":"66","author":"Hocquart","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/1751-2980.13134","article-title":"Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital","volume":"23","author":"Mironova","year":"2022","journal-title":"J Dig Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib7","article-title":"Fecal microbiota transplantation for fulminant Clostridioides difficile infection: a combined medical and surgical case series","volume":"15","author":"Spartz","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.cgh.2026.05.007_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/apt.15526","article-title":"Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients","volume":"50","author":"Tixier","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.05.007_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/ice.2022.304","article-title":"SHEA\/IDSA\/APIC practice recommendation: strategies to prevent healthcare-associated infections through hand hygiene: 2022 update","volume":"44","author":"Glowicz","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2026.05.007_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1017\/ice.2023.18","article-title":"Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update","volume":"44","author":"Kociolek","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2026.05.007_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2022.102543","article-title":"Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settings","volume":"75","author":"Jo","year":"2022","journal-title":"Anaerobe"},{"key":"10.1016\/j.cgh.2026.05.007_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jhin.2022.04.016","article-title":"Matching Clostridioides difficile strains obtained from shoe soles of healthcare workers epidemiologically linked to patients and confirmed by whole-genome sequencing","volume":"126","author":"Buchler","year":"2022","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cgh.2026.05.007_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4065\/75.10.991","article-title":"Reperfusion for acute myocardial infarction: is the future in plastics?","volume":"75","author":"Rao","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2026.05.007_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jam.13653","article-title":"High prevalence of Clostridium difficile on retail root vegetables, Western Australia","volume":"124","author":"Lim","year":"2018","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.cgh.2026.05.007_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8925","article-title":"Association of household exposure to primary Clostridioides difficile infection with secondary infection in family members","volume":"3","author":"Miller","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cgh.2026.05.007_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.gastro.2024.01.008","article-title":"AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases","volume":"166","author":"Peery","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.05.007_bib18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/DCR.0000000000002047","article-title":"The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of Clostridioides difficile infection","volume":"64","author":"Poylin","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2026.05.007_bib20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.007_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae244","article-title":"Impact of the reverse 2-step algorithm for Clostridioides difficile testing in the microbiology laboratory on hospitalized patients","volume":"11","author":"Hilt","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41579-025-01242-2","article-title":"Clostridioides difficile pathogenesis and control","volume":"24","author":"Chilton","year":"2026","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cgh.2026.05.007_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae104","article-title":"Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)","author":"Miller","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib24","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1001\/jamainternmed.2015.4114","article-title":"Overdiagnosis of Clostridium difficile infection in the molecular test era","volume":"175","author":"Polage","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2026.05.007_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13017-019-0228-3","article-title":"2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients","volume":"14","author":"Sartelli","year":"2019","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.cgh.2026.05.007_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/apt.14816","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions","volume":"48","author":"Ianiro","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.05.007_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/19490976.2016.1273998","article-title":"Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: a promising treatment approach","volume":"8","author":"Fischer","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cgh.2026.05.007_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0041-1740973","article-title":"Fulminant Clostridioides difficile infection: a review of treatment options for a life-threatening infection","volume":"43","author":"Carlson","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cgh.2026.05.007_bib29","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/cid\/ciy1077","article-title":"What is the role for metronidazole in the treatment of Clostridium difficile infection? Results from a national cohort study of veterans with initial mild disease","volume":"69","author":"Appaneal","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s10620-019-05900-3","article-title":"Clinical predictors of recurrence after primary Clostridioides difficile infection: a prospective cohort study","volume":"65","author":"Allegretti","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2026.05.007_bib31","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1017\/ash.2021.194","article-title":"Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection","volume":"1","author":"Zhang","year":"2021","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.cgh.2026.05.007_bib32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/ciab718","article-title":"Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.05.007_bib34","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults","volume":"3","author":"Nelson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2026.05.007_bib35","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2025.04.027","article-title":"Dietary fiber modulates the window of susceptibility to Clostridioides difficile infection","volume":"169","author":"Hewlett","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.05.007_bib36","article-title":"Probiotic applications associated with psyllium fiber as prebiotics geared to a healthy intestinal microbiota: a review","volume":"103\u2013104","author":"Martellet","year":"2022","journal-title":"Nutrition"},{"key":"10.1016\/j.cgh.2026.05.007_bib37","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1086\/596711","article-title":"Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis","volume":"48","author":"Koo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmi.2017.12.005","article-title":"How to: diagnose infection caused by Clostridium difficile","volume":"24","author":"Gateau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2026.05.007_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/649016","article-title":"Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection","volume":"31","author":"Sethi","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2026.05.007_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211050443","article-title":"Kinetics of polymerase chain reaction positivity in patients with Clostridioides difficile infection","volume":"14","author":"Saha","year":"2021","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.007_bib41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1473-3099(17)30751-X","article-title":"Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b\/4 trial","volume":"18","author":"Guery","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14787210.2022.1997588","article-title":"Systematic review and meta-analysis: efficacy of vancomycin taper and pulse regimens in Clostridioides difficile infection","volume":"20","author":"Sehgal","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cgh.2026.05.007_bib43","doi-asserted-by":"crossref","first-page":"628","DOI":"10.14309\/ajg.0000000000003844","article-title":"Diagnosis and management of Clostridioides difficile","volume":"121","author":"Kelly","year":"2026","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.007_bib44","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s40121-024-01007-z","article-title":"Integrated safety and efficacy analyses of phase 3 trials of a microbiome therapeutic for recurrent CDI","volume":"13","author":"Kraft","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cgh.2026.05.007_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf117","article-title":"Safety and efficacy of fecal microbiota, live-jslm, in preventing recurrent Clostridioides difficile infection in participants who were mildly to moderately immunocompromised in the phase 3 PUNCH CD3-OLS study","volume":"12","author":"Alonso","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12879-023-08096-0","article-title":"The burden of CDI in the United States: a multifactorial challenge","volume":"23","author":"Feuerstadt","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12879-019-3676-1","article-title":"Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib48","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/cix684","article-title":"Early antibiotic use after fecal microbiota transplantation increases risk of treatment failure","volume":"66","author":"Allegretti","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/00365548.2010.544671","article-title":"Systemic absorption of oral vancomycin in patients with Clostridium difficile infection","volume":"43","author":"Rao","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cgh.2026.05.007_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106311","article-title":"Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection","volume":"57","author":"O'Donnell","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cgh.2026.05.007_bib51","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/AAC.35.12.2602","article-title":"Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery","volume":"35","author":"Martin","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cgh.2026.05.007_bib52","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmi.2023.01.026","article-title":"Intravenous metronidazole for fulminant Clostridioides difficile infection","volume":"29","author":"Pipitone","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2026.05.007_bib54","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/jcag\/gwab023","article-title":"Fecal microbiota transplantation for severe or fulminant Clostridioides difficile infection: systematic review and meta-analysis","volume":"5","author":"Song","year":"2022","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1016\/j.cgh.2026.05.007_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2026.03.023","article-title":"Fecal microbiota transplantation rapidly reduces systemic inflammation and resolves C. difficile pseudomembranous colitis","author":"Khoruts","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.007_bib56","doi-asserted-by":"crossref","first-page":"S-16","DOI":"10.1016\/S0016-5085(24)00530-4","article-title":"41 patient outcomes of intestinal microbiota transplantation for severe and fulminant Clostridioides difficile infection: results from a national registry","volume":"166","author":"Vaughn","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.05.007_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.17834","article-title":"Oral vancomycin for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial","volume":"8","author":"Keating","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cgh.2026.05.007_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00031-18","article-title":"American gut: an open platform for citizen science microbiome research","volume":"3","author":"McDonald","year":"2018","journal-title":"mSystems"},{"key":"10.1016\/j.cgh.2026.05.007_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1028267","article-title":"The impact of dietary fibers on Clostridioides difficile infection in a mouse model","volume":"12","author":"Wu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cgh.2026.05.007_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101474","article-title":"Citrulline inhibits Clostridioides difficile infection with anti-inflammatory effects","volume":"19","author":"Xie","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.05.007_bib61","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/nu17050859","article-title":"The detrimental impact of ultra-processed foods on the human gut microbiome and gut barrier","volume":"17","author":"Rondinella","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.cgh.2026.05.007_bib62","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1128\/AAC.00252-09","article-title":"Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection","volume":"53","author":"Nerandzic","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cgh.2026.05.007_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.01.008","article-title":"Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis","author":"D'Silva","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2026.05.007_bib64","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2562341","article-title":"Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Floria","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cgh.2026.05.007_bib65","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/jcm15010230","article-title":"A vanished association between proton pump inhibitors and Clostridioides difficile infection after minimizing bias","volume":"15","author":"Wu","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.cgh.2026.05.007_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.adaj.2014.11.012","article-title":"The use of prophylactic antibiotics prior to dental procedures in patients with prosthetic joints: evidence-based clinical practice guideline for dental practitioners--a report of the American Dental Association Council on Scientific Affairs","volume":"146","author":"Sollecito","year":"2015","journal-title":"J Am Dent Assoc"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526003587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:03:41Z","timestamp":1787306621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526003587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1542356526003587"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.05.007","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}